The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.

about

Molecular docking studies on thirteen fluoroquinolines with human topoisomerase II a and b.A Systematic Review of Computational Drug Discovery, Development, and Repurposing for Ebola Virus Disease Treatment.

P2860

Q40151282-F55684E8-E8DC-440D-89AC-6CF16493D133 Q44105963-488EB852-34BD-44BF-93E6-39954DADD764

P2860

The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.

Item

http://www.wikidata.org/entity/Q40250981

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

The antibacterial agent, moxif ...... bicans through multitargeting.

@en

type

Item

label

The antibacterial agent, moxif ...... bicans through multitargeting.

@en

prefLabel

The antibacterial agent, moxif ...... bicans through multitargeting.

@en

P1476

The antibacterial agent, moxif ...... bicans through multitargeting.

@en

P2093

Amruta Shelar

http://www.w3.org/2001/XMLSchema#string

Ashwini Jadhav

http://www.w3.org/2001/XMLSchema#string

Bhagyashree Bansode

http://www.w3.org/2001/XMLSchema#string

Datta Phule

http://www.w3.org/2001/XMLSchema#string

Kiran Kharat

http://www.w3.org/2001/XMLSchema#string

Sankunny Mohan Karuppayil

http://www.w3.org/2001/XMLSchema#string

Wasudev Gade

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting DNA topoisomerase II in cancer chemotherapy

In vitro and in vivo antifungal activities of DU-6859a, a fluoroquinolone, in combination with amphotericin B and fluconazole against pathogenic fungi

In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin

The Phyre2 web portal for protein modeling, prediction and analysis

NRG1, a repressor of filamentous growth in C.albicans, is down-regulated during filament induction

Docking studies on novel analogues of 8 methoxy fluoroquinolones against GyrA mutants of Mycobacterium tuberculosis.

Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production

Fungal biofilms and drug resistance.

Fungal keratitis responsive to moxifloxacin monotherapy

Comparative pharmacodynamic interaction analysis between ciprofloxacin, moxifloxacin and levofloxacin and antifungal agents against Candida albicans and Aspergillus fumigatus.

P2888

s11274-017-2264-z

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11274-017-2264-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rajendra H Patil

P577

2017-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084813453

http://www.w3.org/2001/XMLSchema#string

P698

28409362

http://www.w3.org/2001/XMLSchema#string

The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.

about

P2860

P2860

The antibacterial agent, moxifloxacin inhibits virulence factors of Candida albicans through multitargeting.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698